Previous Close | 128.90 |
Open | 128.90 |
Bid | 129.00 |
Ask | 138.00 |
Strike | 410.00 |
Expire Date | 2025-01-17 |
Day's Range | 128.90 - 128.90 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
It's been a good week for Biogen Inc. ( NASDAQ:BIIB ) shareholders, because the company has just released its latest...
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.